Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210309050653N1Phase 3Completed
Phase 3, open-label trial of propofol, sevoflurane and remifentanil in None (4 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Mean bispectral index values, Mean arterial pressure change and 1 more. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210309050653N1.